Skip to Main Content

Paper Details

Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.
J Hepatol
7
2021
Author NameAffiliation
Craig W NewcombCenter for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania
Amy C JusticeVA Connecticut Healthcare System, Yale School of Medicine, Yale School of Public Health
Vincent Lo RePerelman School of Medicine, University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training
  • 1 - 3

Datasets

Release 1.2